- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02950532
Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures (PAM)
August 11, 2020 updated by: AO Clinical Investigation and Publishing Documentation
Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures (T11-L2): A Diagnostic Test Study to Analyze Sensitivity and Specificity
The objective of this investigation is to confirm the results obtained in a pilot study showing that certain radiological parameters based on computed tomography (CT) scans seem to reliably detect posterior ligament complex (PLC) injury without the need for Magnetic Resonance Imaging (MRI)
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Integrity of posterior ligament complex (PLC) has an important bearing on the treatment strategies for thoracolumbar (TL) fractures.
Magnetic Resonance Imaging (MRI) is the gold standard to confirm PLC injury.
The routine use of MRI has its limitations especially since in most trauma centers MRI is not the primary assessment for TL fractures due to reduced availability, increased cost and its adverse applicability in trauma setting and in case of a polytrauma.
In contrast computed tomography (CT) scans are an integral part of trauma evaluation protocols, are accurate in spine fracture diagnosis and are performed in less time, making them suitable to assess polytrauma scenarios.
In a recent pilot study, a number of radiological parameters based on CT scans have shown to reliably detect PLC injury when compared to MRI.
The aim of the study is to reconfirm and validate these CT based parameters to assess PLC injury compared to MRI.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hangzhou, China, 310003
- The 1st Affiliated Hospital of Zhejiang University
-
-
-
-
-
Assiut, Egypt, 71526
- Assiut Universtiy Hospitals
-
-
-
-
-
Coimbatore, India, 641 011
- Ganga Hospital
-
-
-
-
-
Uijeongbu-si, Korea, Republic of, 118765
- Uijeongbu St. Mary's Hospital
-
-
-
-
-
Belfast, United Kingdom, BT12 6BA
- Royal Victoria Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The participating study sites will retrospectively identify all eligible patients in the medical charts (i.e. who meet all of the inclusion and none of the exclusion criteria).
If required by local regulations, patients choosing to participate will sign and date an informed consent form (ICF).
Description
Inclusion Criteria:
- Age 18 to 60 years
- A3/A4 TL fracture between T11-L2 with or without PLC injury
- Pre-treatment CT scan and MRI. Radiographs (if available)
- Signed Informed consent, if required by EC/IRB
Exclusion Criteria:
- Pathological fractures
- Multilevel contiguous and non-contiguous injuries
- Fractures with obvious spinous process split indicating tension band failure such as AO type B1 injuries
- Fractures with translation injuries or dislocations such as AO type C injuries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Cases
Retrospective radiological evaluation in cases presenting A3 or A4 TL burst fractures (AOSpine classification) between T11 to L2 with or without suspected PLC injury
|
Radiological evaluation will be performed in already existing imaging exams.
Superior-inferior end plate angle (SIEA), vertebral body height (BH), local kyphosis (LK), inter-spinous distance (ISD) and inter-pedicular distance (IPD) will be measured in CT scans and radiographs (if available).
PLC injury will be determinated with the gold standard method (MRI).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity of Local kyphosis (LK) and/or Inter-spinous distanceI (SD)
Time Frame: CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Sensitivity of LK and/or ISD Is defined as the proportion of patients with PLC injury correctly diagnosed by an increase in LK and/or ISD difference compared to MRI.
The Specificity si defined as the proportion of patients with PLC injury correctly diagnosed by an increase in LK and/or ISD difference compared to MRI.
The gold standard is a diagnostic test and it is the best accepted test that is assumed to be able to determine the true disease state.
It is considered as the reference method or the best test available.
|
CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity and specificity of superior-inferior end plate angle (SIEA)
Time Frame: CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Is defined as the proportion of patients with PLC injury correctly diagnosed by a increase in SIEA compared to MRI.
|
CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
|
Sensitivity and specificity of vertebral body height (BH)
Time Frame: CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Is defined as the proportion of patients with PLC injury correctly diagnosed by an decrease in BH compared to MRI.
|
CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
|
Sensitivity and specificity of inter-pedicular distance (IPD)
Time Frame: CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Is defined as the proportion of patients with PLC injury correctly diagnosed by a increase in IPD compared to MRI.
|
CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of CT scan measurements
Time Frame: CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Accuracy describes how closely the measured value is to the true value and is an indicator of systematic errors.
The accuracy of measurements of each CT scan parameter will be compared between the participating sites.
|
CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
|
Inter-rater reliability
Time Frame: CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
The inter-rater reliability is defined as the percent agreement between the measurements of the different parameters by the different observers.
The CT scans and radiographs (if available) distributed to the participating sites will be measured at each site by all participating MDs within each team or at least by one trained PI.
|
CT scans, MRI and x-rays were taken on admission into hospital after the patient got a thoracolumbar fracture. These images will be retrospectively analyzed (eligible images are from the date of the fracture up to 3 days after the event).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Shanmuganathan Rajasekaran, Prof. MD, Ganga Hospital
- Study Chair: Test Testing, MD, TESTING
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2016
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
June 1, 2018
Study Registration Dates
First Submitted
October 18, 2016
First Submitted That Met QC Criteria
October 28, 2016
First Posted (Estimate)
November 1, 2016
Study Record Updates
Last Update Posted (Actual)
August 13, 2020
Last Update Submitted That Met QC Criteria
August 11, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AOCID_PAM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
Publication
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.